NL-OMON25453已完成不适用
ycopene and Vitamin E in men with minimal prostate cancer and rising PSA after radical prostatectomy. A double blind randomised placebo controlled cross-over study.
BASF Aktiengesellschaft.0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
Schroder FH, Roobol MJ, Boeve ER, de Mutsert R, Zuijdgeest-van Leeuwen SD, Kersten I, Wildhagen MF, van Helvoort A.
Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Eur Urol. 2005 Dec;48(6):922-30; discussion 930-1. Epub 2005 Oct 17.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Status after radical prostatectomy with potential curative intent;
- •2. Rising PSA;
排除标准
- •1. Current hormone therapy or hormone therapy during previous 12 months;
- •2. Orchidectomy;
研究者
相似试验
已完成
不适用
ycopene and vitamin E in men with minimal prostate cancer and rising prostate specific antigen after radical prostatectomy: a double blind randomised placebo controlled cross-over studyMalignant neoplasm of prostateProstate cancerCancerISRCTN02859773BASF Aktiengesellschaft (Germany)80
进行中（未招募）
不适用
Prostate Phytochemical & PUFA Intervention (PFPI)Norwegian title: Prostata Fytokjemikalie & PUFA Intervensjon (PFPI) - PFPIocalized cancer of the prostate.EUCTR2006-006679-18-NOniversity of Oslo, institute for basic medical sciences, department of nutrition.
已完成
1 期
Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate CancerProstate CancerNCT00895115University of Medicine and Dentistry of New Jersey65
尚未招募
2 期
Investigating the effectiveness of vitamin E drug in reducing the incidence of chronic neurotoxicity caused by oxaliplatin drugDrug-induced neurotoxicity.Drug-induced neurotoxicity62.0IRCT20180313039085N3Iran University of Medical Sciences60
终止
3 期
Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate CancerProstate CancerNCT00809458New Mexico Cancer Care Alliance15